These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 25411578)

  • 21. [Resolvins as novel targets for rapid-acting antidepressants].
    Deyama S
    Nihon Yakurigaku Zasshi; 2020; 155(6):381-385. PubMed ID: 33132254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Rapidly Acting Antidepressant Ketamine and the mGlu2/3 Receptor Antagonist LY341495 Rapidly Engage Dopaminergic Mood Circuits.
    Witkin JM; Monn JA; Schoepp DD; Li X; Overshiner C; Mitchell SN; Carter G; Johnson B; Rasmussen K; Rorick-Kehn LM
    J Pharmacol Exp Ther; 2016 Jul; 358(1):71-82. PubMed ID: 27189960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of AMPA receptor stimulation and TrkB signaling in the antidepressant-like effect of ketamine co-administered with a group II mGlu receptor antagonist, LY341495, in the forced swim test in rats.
    Pałucha-Poniewiera A; Podkowa K; Pilc A
    Behav Pharmacol; 2019 Sep; 30(6):471-477. PubMed ID: 30724804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glutamate modulators as novel interventions for mood disorders.
    Mathew SJ; Keegan K; Smith L
    Braz J Psychiatry; 2005 Sep; 27(3):243-8. PubMed ID: 16224615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of glutamatergic modulation in the mechanism of action of ketamine, a prototype rapid-acting antidepressant drug.
    Pałucha-Poniewiera A
    Pharmacol Rep; 2018 Oct; 70(5):837-846. PubMed ID: 30086517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute administration of ketamine attenuates the impairment of social behaviors induced by social defeat stress exposure as juveniles via activation of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors.
    Hasegawa S; Yoshimi A; Mouri A; Uchida Y; Hida H; Mishina M; Yamada K; Ozaki N; Nabeshima T; Noda Y
    Neuropharmacology; 2019 Apr; 148():107-116. PubMed ID: 30590060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of glutamate on the action of antidepressants.
    Hashimoto K
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1558-68. PubMed ID: 20600468
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methoxetamine produces rapid and sustained antidepressant effects probably via glutamatergic and serotonergic mechanisms.
    Botanas CJ; Bryan de la Peña J; Custodio RJ; Joy Dela Peña I; Kim M; Woo T; Kim HJ; Kim HI; Chang Cho M; Lee YS; Cheong JH
    Neuropharmacology; 2017 Nov; 126():121-127. PubMed ID: 28867363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mood disorders: regulation by metabotropic glutamate receptors.
    Pilc A; Chaki S; Nowak G; Witkin JM
    Biochem Pharmacol; 2008 Mar; 75(5):997-1006. PubMed ID: 18164691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of NMDA receptor in neurobiology and treatment of major depressive disorder: Evidence from translational research.
    Amidfar M; Woelfer M; Réus GZ; Quevedo J; Walter M; Kim YK
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Aug; 94():109668. PubMed ID: 31207274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fast-acting antidepressant activity of ketamine: highlights on brain serotonin, glutamate, and GABA neurotransmission in preclinical studies.
    Pham TH; Gardier AM
    Pharmacol Ther; 2019 Jul; 199():58-90. PubMed ID: 30851296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Essential roles of AMPA receptor GluA1 phosphorylation and presynaptic HCN channels in fast-acting antidepressant responses of ketamine.
    Zhang K; Xu T; Yuan Z; Wei Z; Yamaki VN; Huang M; Huganir RL; Cai X
    Sci Signal; 2016 Dec; 9(458):ra123. PubMed ID: 27965425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synaptic mechanisms underlying rapid antidepressant action of ketamine.
    Kavalali ET; Monteggia LM
    Am J Psychiatry; 2012 Nov; 169(11):1150-6. PubMed ID: 23534055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression.
    Koike H; Iijima M; Chaki S
    Behav Brain Res; 2011 Oct; 224(1):107-11. PubMed ID: 21669235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antidepressant effects of ketamine and the roles of AMPA glutamate receptors and other mechanisms beyond NMDA receptor antagonism.
    Aleksandrova LR; Phillips AG; Wang YT
    J Psychiatry Neurosci; 2017 Jun; 42(4):222-229. PubMed ID: 28234212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The rapid-onset antidepressant effect of ketamine: More surprises?
    Raffa RB; Pergolizzi JV; Taylor R;
    J Clin Pharm Ther; 2018 Apr; 43(2):308-311. PubMed ID: 29178131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ketamine, magnesium and major depression--from pharmacology to pathophysiology and back.
    Murck H
    J Psychiatr Res; 2013 Jul; 47(7):955-65. PubMed ID: 23541145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced mGlu5 Signaling in Excitatory Neurons Promotes Rapid Antidepressant Effects via AMPA Receptor Activation.
    Holz A; Mülsch F; Schwarz MK; Hollmann M; Döbrössy MD; Coenen VA; Bartos M; Normann C; Biber K; van Calker D; Serchov T
    Neuron; 2019 Oct; 104(2):338-352.e7. PubMed ID: 31420117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ketamine in Major Depressive Disorder: Mechanisms and Future Perspectives.
    Shin C; Kim YK
    Psychiatry Investig; 2020 Mar; 17(3):181-192. PubMed ID: 32209965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ketamine's antidepressant action: beyond NMDA receptor inhibition.
    Hashimoto K
    Expert Opin Ther Targets; 2016 Nov; 20(11):1389-1392. PubMed ID: 27646666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.